Casdin Capital, LLC 13D and 13G filings for Century Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-27 6:51 pm Purchase | 2024-11-20 | 13G | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 4,592,316 5.400% | 1,380,000 (+42.96%) | Filing |
| 2024-11-14 4:08 pm Sale | 2024-09-30 | 13G | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 3,212,316 3.800% | -1,978,190 (-38.11%) | Filing |
| 2024-04-18 4:36 pm Purchase | 2024-04-11 | 13G | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 5,190,506 6.080% | 1,984,126 (+61.88%) | Filing |
| 2024-04-08 9:03 pm Sale | 2024-02-29 | 13D | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 3,206,380 4.950% | -16,560 (-0.51%) | Filing |
| 2022-10-11 2:09 pm Sale | 2022-10-01 | 13D | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 3,222,940 5.500% | -23,184 (-0.71%) | Filing |
| 2021-07-29 2:11 pm Purchase | 2021-06-17 | 13D | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 3,246,124 5.900% | 3,246,124 (New Position) | Filing |